Here in the Anglia Ruskin Clinical Trials Unit (ARCTU), we're able to support access to commercial studies through our partnership with Quintiles.
With a global team of 50,000 employees conducting business in approximately 100 countries, Quintiles is the world’s largest Contract Research Organisation (CRO).
Quintiles applies insights, commercial and scientific depth, and executional expertise to help customers navigate an increasingly complex healthcare environment, as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes.
ARCTU supports the delivery of studies from the Quintiles pipeline at our local partner trusts. Since the inception of the partnership, we have seen substantial growth in our commercial studies across all partner trusts and various therapeutic areas.
To learn more about Quintiles, please visit www.quintiles.com.